Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsTOPICALGeneric

SHADE UVAGUARD

AVOBENZONE; OCTINOXATE; OXYBENZONE

Standard Dose
3%;7.5%;3%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview SHADE UVAGUARD is listed in Drugs@FDA under application 020045 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient AVOBENZONE; OCTINOXATE; OXYBENZONE Form and strength LOTION;TOPICAL - 3%;7.5%;3% Sponsor BAYER HEALTHCARE LLC Submission history Latest submission status date: 1996-08-22 00:00:00.

Structured Monograph

Clinical summary

Approval overview SHADE UVAGUARD is listed in Drugs@FDA under application 020045 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient AVOBENZONE; OCTINOXATE; OXYBENZONE Form and strength LOTION;TOPICAL - 3%;7.5%;3% Sponsor BAYER HEALTHCARE LLC Submission history Latest submission status date: 1996-08-22 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.